INROADS: an international registry of Alzheimer's disease patients - ongoing clinical trial

被引：0
|
作者：
Stern, R. A. [1 ]
Arrighi, H. M. [2 ]
Lacey, L. A. [3 ]
Rippon, G. A. [4 ]
Menon, V. [5 ]
Ropacki, M. T. [2 ]
机构：
[1] Boston Univ, Boston, MA 02215 USA
[2] Janssen Alzheimer Immunotherapy R&D LLC, San Francisco, CA USA
[3] Janssen Alzheimer Immunotherapy, Dublin, Ireland
[4] Pfizer Inc, Collegeville, PA USA
[5] Outcome Sci, Cambridge, MA USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2012年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：473 / 473
页数：1
相关论文
共 50 条
  • [1] Clinical trial of donepezil on patients with Alzheimer's disease
    Zhang, X. Q.
    Dong, H. Q.
    Min, B. Q.
    JOURNAL OF ALZHEIMERS DISEASE, 2002, 4 (01) : 64 - 64
  • [2] Immunotherapy for Alzheimer's Disease: Rational Basis in Ongoing Clinical Trials
    Menendez-Gonzalez, Manuel
    Perez-Pinera, Pablo
    Martinez-Rivera, Marta
    Lopez Muniz, Alfonso
    Vega, Jose A.
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (05) : 508 - 520
  • [3] Ongoing trials in Alzheimer's disease
    Sramek, JJ
    Cutler, NR
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (04) : 899 - 915
  • [4] Why participate in an Alzheimer's disease clinical trial? Is it of benefit to carers and patients?
    Mastwyk, M
    MacFarlane, S
    LoGiudice, D
    Sullivan, KA
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 (02) : 149 - 156
  • [5] Efficacy and safety of rivastigmine in patients with Alzheimer's disease:: international randomised controlled trial
    Rösler, M
    Anand, R
    Cicin-Sain, A
    Gauthier, S
    Agid, Y
    Dal-Bianco, P
    Stähelin, HB
    Hartman, R
    Gharabawi, M
    BMJ-BRITISH MEDICAL JOURNAL, 1999, 318 (7184): : 633 - 638
  • [6] The consortium to establish a registry for Alzheimer's disease (CERAD) .14. Demographic and clinical predictors of survival in patients with Alzheimer's
    Heyman, A
    Peterson, B
    Fillenbaum, G
    Pieper, C
    NEUROLOGY, 1996, 46 (03) : 656 - 660
  • [7] Rapamycin and Alzheimer's disease: Time for a clinical trial?
    Kaeberlein, Matt
    Galvan, Veronica
    SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (476)
  • [8] Motivators for Alzheimer’s disease clinical trial participation
    Shoshana H. Bardach
    Sarah D. Holmes
    Gregory A. Jicha
    Aging Clinical and Experimental Research, 2018, 30 : 209 - 212
  • [9] MOTIVATORS FOR ALZHEIMER'S DISEASE CLINICAL TRIAL PARTICIPATION
    Bardach, S.
    Holmes, S. D.
    Jicha, G.
    GERONTOLOGIST, 2016, 56 : 205 - 206
  • [10] Motivators for Alzheimer's disease clinical trial participation
    Bardach, Shoshana H.
    Holmes, Sarah D.
    Jicha, Gregory A.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 30 (02) : 209 - 212
12345